Carna Biosciences, Inc. (TYO:4572)
Japan flag Japan · Delayed Price · Currency is JPY
309.00
-8.00 (-2.52%)
Nov 18, 2026, 10:20 AM JST

Carna Biosciences Financials Overview

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
756.575796361,6251,3862,017
Revenue Growth
38.96%-8.96%-60.86%17.24%-31.28%78.02%
Gross Profit
535.313884651,4501,2151,882
Operating Income
-2,056-2,075-2,076-1,117-1,270-531
Net Income
-2,204-2,171-2,178-1,152-1,349-534
Earnings Per Share
-111.01-113.60-121.61-68.57-99.06-42.06
EPS Growth
------

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Europe
47.7161.29112.9572.0280.97
United States of America
259.61276.86---
Others
5.996.826.3337.8817.89
Japan
169.19198.82223.31218.75205.06
China
96.5592.47128.72202.9271.77
Total
579.06636.231,6261,3872,018

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5445162,1082,8893,3793,817
Total Debt
1,88571359182299539
Net Cash (Debt)
-1,341-1972,0492,7073,0803,278
Net Cash Growth
---24.31%-12.11%-6.04%-15.32%
Net Cash Per Share
-67.54-10.31114.41161.13226.18258.20

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--2,159-1,374-1,677-708-1,536
Capital Expenditures
--9-13-11-126-41
Free Cash Flow
--2,168-1,387-1,688-834-1,577
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
70.75%67.01%73.11%89.23%87.66%93.31%
Operating Margin
-271.77%-358.38%-326.41%-68.74%-91.63%-26.33%
Pretax Margin
-291.09%-374.78%-341.82%-69.54%-95.45%-26.43%
Profit Margin
-291.31%-374.96%-342.45%-70.89%-97.33%-26.47%
FCF Margin
--374.44%-218.08%-103.88%-60.17%-78.19%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-137.38137.38137.38137.38137.38
PS Ratio
9.7111.779.015.515.337.27